Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2352
  • Dowloads 137

Case Reports

Open Access

Malignancy-transformed mature cystic teratoma surgical treatment requires comprehensive staging procedures including pelvic/para-aortic lymphadenectomy

  • B. Barczyński1,*,
  • K. Frąszczak1
  • M. Bilski2
  • J. Szumiło3
  • I. Wertel1
  • M. Sobstyl4
  • G. Polak1
  • L. Grzybowska-Szatkowska5
  • J. Kotarski1

1I Department of Oncological Gynaecology and Gynaecology, Medical University of Lublin, Lublin, Poland

2Nu-med, Center of Oncology Diagnostics and Therapy, Zamość, Poland

3Department of Clinical Pathomorphology, Medical University of Lublin, Lublin, Poland

4Department of Gynaecology and Gynaecological Endocrinology, Medical University of Lublin, Lublin, Poland

5I Department of Radiation Therapy, Center of Oncology of the Lublin Region St. John from Dukla, Lublin, Poland

DOI: 10.31083/j.ejgo.2020.03.5146 Vol.41,Issue 3,June 2020 pp.484-488

Submitted: 27 January 2019 Accepted: 01 April 2019

Published: 15 June 2020

*Corresponding Author(s): B. Barczyński E-mail: bbarczynski@poczta.onet.pl

PDF (418.49 kB) View Full-text

Abstract

This report presents the case of squamous cell cancer (SCC) originating from a mature cystic teratoma (MCT) diagnosed in pregnant women, in whom retroperitoneal spread to para-aortic lymph nodes was confirmed as the only evidence of extraovarian disease in a relatively short time after primary tumor excision. The 35-year-old multipara was diagnosed in early pregnancy with an ovarian tumor. The patient qualified for elective caesarean section with left ovarian cystectomy. Pathological result proved SCC in MCT and the patient underwent debulking surgery without total pelvic and para-aortic lymphadenectomy. Final staging confirmed ovarian malignancy FIGO IA, and no adjuvant treatment was recommended. Early imaging examination during routine follow-up demonstrated enlarged para-aortic lymph nodes and the patient qualified for total pelvic and para-aortic lymphadenectomy. Postoperative pathology result confirmed metastases in para-aortic lymph nodes and standard adjuvant chemotherapy was administered.

Keywords

Malignancy-transformed mature cystic teratoma; Para-aortic lymphadenectomy

Cite and Share

B. Barczyński,K. Frąszczak,M. Bilski,J. Szumiło,I. Wertel,M. Sobstyl,G. Polak,L. Grzybowska-Szatkowska,J. Kotarski. Malignancy-transformed mature cystic teratoma surgical treatment requires comprehensive staging procedures including pelvic/para-aortic lymphadenectomy. European Journal of Gynaecological Oncology. 2020. 41(3);484-488.

URL:

https://www.ejgo.net/articles/10.31083/j.ejgo.2020.03.5146

References

[1] Leiserowitz G.S., Xing G., Cress R., Brahmbhatt B., Dalrymple J.L., Smith L.H.: “Adnexal masses in pregnancy: how often are they malignant?”. Gynecol. Oncol., 2006, 101, 315.

[2] Sayar H., Lhomme C., Verschraegen C.F.: “Malignant adnexal masses in pregnancy”. Obstet. Gynecol. Clin. North. Am., 2005, 32, 569.

[3] Goudeli C., Varytimiadi A., Koufopoulos N., Syrios J., Terzakis E.: “An ovarian mature cystic teratoma evolving in squamous cell carcinoma: A case report and review of the literature”. Gynecol. Oncol. Rep., 2016, 18, 27.

[4] Marino T., Craigo S.D.: “Managing adnexal masses in pregnancy”. Contemp. Ob/Gyn. 2000, 45, 130.

[5] Chen R.J., Chen K.Y., Chang T.C., Sheu B.C., Chow S.N., Huang S.C.: “Prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary”. J. Formos. Med. Assoc., 2008, 107, 857.

[6] Mori Y., Nishii H., Takabe K., Shinozaki H., Matsumoto N., Suzuki K., et al.: ”Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary”. Gynecol. Oncol., 2003, 90, 338.

[7] Yamanaka Y., Tateiwa Y., Miyamoto H., Umemoto Y., Takeuchi Y., Katayama K., Hashimoto K.: „Preoperative diagnosis of malignant transformation in mature cystic teratoma of the ovary”. Eur. J. Gynaecol. Oncol. 2005, 26, 391.

[8] Park C.H., Jung M.H., Ji Y.I.: “Risk factors for malignant transfor- mation of mature cystic teratoma”. Obstet. Gynecol. Sci. 2015, 58, 475.

[9] Kikkawa F., Nawa A., Tamakoshi K., Ishikawa H., Kuzuya K., Suganuma N., et al.: “Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary”. Cancer. 1998, 82, 2249.

[10] Togami S., Kawamura T., Kamio M., Douchi T.: “A rare case of microinvasive squamous cell carcinoma arising in mature cystic teratoma of the ovary”. Eur. J. Gynaecol. Oncol. 2016, 37, 420.

[11] Kawai M., Kano T., Kikkawa F., Morikawa Y., Oguchi H., Nakashima N., et al. “Seven tumor markers in benign and malignant germ cell tumors of the ovary”. Gynecol. Oncol. 1992, 45, 248.

[12] Jung S.I.: “Ultrasonography of ovarian masses using a pattern recognition approach”. Ultrasonography. 2015, 34, 173.

[13] Shin H.J., Kim K.A., Kim B.H., Lee J.K., Park Y.S., Lee J., et al.: “Benign enhancing components of mature ovarian teratoma: magnetic resonance imaging features and pathologic correlation”. Clin. Imaging, 2016, 40, 1156.

[14] Dos Santos L., Mok E., Iasonos A., Park K., Soslow R.A., Aghajanian C., et al.: “Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature”. Gynecol. Oncol., 2007, 105, 321.

[15] Ulker V., Gedikbasi A., Numanoglu C., Ozluk Y., Saygi S., Gulki- lik A., Salihoglu Y.: “Mucinous adenocarcinoma arising in ovarian mature cystic teratoma in pregnancy”. Arch. Gynecol. Obstet. 2009, 280, 287.

[16] Kusunoki S., Huang K.G., Magno A., Lee C.L.: ”Laparoscopic technique of para-aortic lymph node dissection: A comparison of the different approaches to transversus extraperitoneal para-aortic lymphadenectomy”. Gynecol. Minim. Invasive. Ther. 2017, 6, 51.

Submission Turnaround Time

Top